PENG Block vs Intrathecal Morphine in Total Hip Arthroplasty
Total Hip Arthroplasty, Postoperative Pain
About this trial
This is an interventional treatment trial for Total Hip Arthroplasty focused on measuring Total hip arthroplasty, Postoperative pain, Anesthesia, Regional
Eligibility Criteria
Inclusion Criteria:
- adult patients with osteoarthritis of the hip scheduled for primary total hip arthroplasty under spinal anesthesia able to provide written informed consent
Exclusion Criteria:
- patient unwilling / unable to provide informed consent
- contraindications for any of the drugs and procedures included in the study protocol (allergies, local infection, coagulopathy)
- high risk for perioperative morbidity/mortality (ASA Physical Status Classification IV)
- preoperative use of strong opioid analgesia (due to hip pain or other acute/chronic pain condition)
- pregnancy
- substance abuse
Post Randomization Exclusion Criteria:
- change of surgical plan
- violation of study protocol
Sites / Locations
- Akromion Special Hospital for Orthopedic Surgery
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
PENG block
Intrathecal morphine
Patients scheduled for primary total hip arthroplasty after receiving spinal anesthesia will undergo pericapsular nerve group (PENG) block. Postoperative multimodal analgesia with paracetamol, etoricoxib and oxycodone
Patients scheduled for primary total hip arthroplasty will receive spinal anesthesia with local anesthetic and morphine administered intrathecally. After onset of spinal anesthesia a sham PENG block will be performed. Postoperative multimodal analgesia with paracetamol, etoricoxib and oxycodone.